首页> 外国专利> ORAL LIQUID FORMULATION HAVING IMPROVED STABILITY COMPRISING AMBROXOL AND LEVODROPROPIZINE

ORAL LIQUID FORMULATION HAVING IMPROVED STABILITY COMPRISING AMBROXOL AND LEVODROPROPIZINE

机译:包含氨溴索和左旋丙嗪的口服液制剂提高了稳定性

摘要

The present invention relates to an oral liquid preparation containing: ambroxol or a pharmaceutically acceptable salt thereof; levodropropizine or a pharmaceutically acceptable salt thereof; and sodium pyrosulfite. The oral liquid preparation of the present invention exhibits a high synergistic effect and patients drug compliance by combining ambroxol and levodropropizine, which have different medicinal action mechanisms, and exhibits excellent storage stability by using sodium pyrosulfite, and thus can be useful as a medicine for treating acute and chronic respiratory diseases without the change in the medicinal effect for a long time.
机译:本发明涉及一种口服液体制剂,其包含:氨溴索或其药学上可接受的盐;和左洛哌嗪或其药学上可接受的盐;和焦亚硫酸钠。本发明的口服液制剂通过具有不同的药理机理的氨溴索和左旋哌嗪嗪组合显示出高的协同作用和对患者的药物依从性,并且通过使用焦亚硫酸钠显示优异的保存稳定性,因此可以用作治疗药物。急慢性呼吸道疾病的药效长期不变。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号